Pathstone Family Office’s Moleculin Biotech MBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-11
Closed -$1K 1242
2020
Q3
$1K Hold
11
﹤0.01% 750
2020
Q2
$1K Buy
+11
New +$1K ﹤0.01% 678